Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11744812 Methods of treatment
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
Date Filed
April 15, 2021
Date of Patent
September 5, 2023
Patent Application Number
17231716
Patent Citations
US Patent 10744103 Methods and compositions for treating conditions associated with an abnormal inflammatory responses
US Patent 10772854 Methods and compositions for treating conditions associated with an abnormal inflammatory response
US Patent 10799468 Methods and compositions for treating conditions associated with an abnormal inflammatory responses
US Patent 10849867 Methods and compositions for treating conditions associated with an abnormal inflammatory response
US Patent 10905666 Methods and compositions for treating conditions associated with an abnormal inflammatory response
US Patent 10912746 Methods and compositions for treating conditions associated with an abnormal inflammatory response
US Patent 10980756 Methods of treatment
US Patent 11045434 Niclosamide formulations for treating disease
US Patent 7132546 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
US Patent 7544712 Treatment of coronavirus infection
•••
Patent Inventor Names
Gary D. Glick
Patent Jurisdiction
United States Patent and Trademark Office
Patent Number
11744812
Patent Primary Examiner
Pancham Bakshi
CPC Code
A61K 31/135
A61K 31/167
A61K 31/685
Find more entities like US Patent 11744812 Methods of treatment
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE